ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment

Background ENDORISK is a Bayesian network that can assist in preoperative risk estimation of lymph node metastasis (LNM) risk in endometrial cancer (EC) with consistent performance in external validations. To reflect state of the art care, ENDORISK was optimized by integrating molecular classificati...

Descripción completa

Detalles Bibliográficos
Autores: Lombaers, Marike, Reijnen, Casper, Sprik, Ally, Bretová, Petra, Grube, Marcel, Vrede, Stephanie, Berg, Hege, Asberger, Jasmin, Colas, Eva, Hausnerova, Jitka, Huvila, Jutta, Gil Moreno, Antonio, Matias-Guiu, Xavier, Simons, Michiel, Snijders, Marc, Visser, Nicole, Kommoss, Stefan, Weinberger, Vit, Amant, Frederic, Bronsert, Peter, Haldorsen, Ingfrid, Koskas, Martin, Krakstad, Camilla, Küsters Vandevelde, Heidi, Mancebo, Gemma, van der Putten, Louis, de la Calle, Irene, Lucas, Peter, Hommersom, Arjen, Pijnenborg, Johanna
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10459.1/469209
Acceso en línea:https://doi.org/10.1016/j.ejca.2025.116058
https://hdl.handle.net/10459.1/469209
http://hdl.handle.net/10459.1/469209
Access Level:acceso abierto
Palabra clave:Bayesian network
Endometrial cancer
Lymph node metastasis
Molecular classification
Myometrial invasion
Risk estimation
id ES_28b3facd4be54fbd82adecbfa55fc725
oai_identifier_str oai:recercat.cat:10459.1/469209
network_acronym_str ES
network_name_str España
repository_id_str
spelling ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessmentLombaers, MarikeReijnen, CasperSprik, AllyBretová, PetraGrube, MarcelVrede, StephanieBerg, HegeAsberger, JasminColas, EvaHausnerova, JitkaHuvila, JuttaGil Moreno, AntonioMatias-Guiu, XavierSimons, MichielSnijders, MarcVisser, NicoleKommoss, StefanWeinberger, VitAmant, FredericBronsert, PeterHaldorsen, IngfridKoskas, MartinKrakstad, CamillaKüsters Vandevelde, HeidiMancebo, Gemmavan der Putten, Louisde la Calle, IreneLucas, PeterHommersom, ArjenPijnenborg, JohannaBayesian networkEndometrial cancerLymph node metastasisMolecular classificationMyometrial invasionRisk estimationBackground ENDORISK is a Bayesian network that can assist in preoperative risk estimation of lymph node metastasis (LNM) risk in endometrial cancer (EC) with consistent performance in external validations. To reflect state of the art care, ENDORISK was optimized by integrating molecular classification and preoperative assessment of myometrial invasion (MI). Methods Variables for POLE, MSI, and preoperative assessment of MI, either by expert transvaginal ultrasound or pelvic magnetic resonance imaging (MRI), were added to develop ENDORISK-2. The p53 biomarker, part of the molecular classification, was already included in ENDORISK. External validation of ENDORISK-2 for LNM prediction was performed in two independent cohorts from: Brno (CZ), (n = 581) and Tübingen (DE), (n = 247). Findings ENDORISK-2 yielded AUCs of 0·85 (95 % CI 0·80–0·90) (CZ) and 0·86 (95 % CI 0·77–0·96) (DE) for predicting LNM. In patients with low-grade histology, 83 % (CZ) and 89 % (DE) were estimated having less than 10 % risk of LNM, with false negative rates (FNR) of 4·3 % (CZ) and 2·2 % (DE). The previously defined set of minimally required variables, i.e.: preoperative tumor grade, three of the four immunohistochemical (IHC) markers, and one clinical marker, could be interchanged with the new variables, with comparable validation metrics, including AUC values of 0·79–0·87 for LNM prediction. Interpretation. Incorporation of molecular data and preoperative MI improved the flexibility of ENDORISK with comparable diagnostic accuracy for estimating LNM as when based on low-cost immunohistochemical biomarkers. In addition, the high diagnostic accuracy in patients with low-grade EC demonstrates how ENDORISK-2 could aid clinicians in identifying patients in whom surgical lymph node assessment may safely be omitted. These results underline its power for clinical use in both high and low resource countries.Elsevier2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://doi.org/10.1016/j.ejca.2025.116058https://hdl.handle.net/10459.1/469209http://hdl.handle.net/10459.1/469209reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a https://doi.org/10.1016/j.ejca.2025.116058European Journal of Cancer, 2025, vol. 231, 116058cc-by, (c) Marike Lombaers et al., 2025Attribution 4.0 Internationalinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/oai:recercat.cat:10459.1/4692092026-05-29T05:05:01Z
dc.title.none.fl_str_mv ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
title ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
spellingShingle ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
Lombaers, Marike
Bayesian network
Endometrial cancer
Lymph node metastasis
Molecular classification
Myometrial invasion
Risk estimation
title_short ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
title_full ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
title_fullStr ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
title_full_unstemmed ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
title_sort ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
dc.creator.none.fl_str_mv Lombaers, Marike
Reijnen, Casper
Sprik, Ally
Bretová, Petra
Grube, Marcel
Vrede, Stephanie
Berg, Hege
Asberger, Jasmin
Colas, Eva
Hausnerova, Jitka
Huvila, Jutta
Gil Moreno, Antonio
Matias-Guiu, Xavier
Simons, Michiel
Snijders, Marc
Visser, Nicole
Kommoss, Stefan
Weinberger, Vit
Amant, Frederic
Bronsert, Peter
Haldorsen, Ingfrid
Koskas, Martin
Krakstad, Camilla
Küsters Vandevelde, Heidi
Mancebo, Gemma
van der Putten, Louis
de la Calle, Irene
Lucas, Peter
Hommersom, Arjen
Pijnenborg, Johanna
author Lombaers, Marike
author_facet Lombaers, Marike
Reijnen, Casper
Sprik, Ally
Bretová, Petra
Grube, Marcel
Vrede, Stephanie
Berg, Hege
Asberger, Jasmin
Colas, Eva
Hausnerova, Jitka
Huvila, Jutta
Gil Moreno, Antonio
Matias-Guiu, Xavier
Simons, Michiel
Snijders, Marc
Visser, Nicole
Kommoss, Stefan
Weinberger, Vit
Amant, Frederic
Bronsert, Peter
Haldorsen, Ingfrid
Koskas, Martin
Krakstad, Camilla
Küsters Vandevelde, Heidi
Mancebo, Gemma
van der Putten, Louis
de la Calle, Irene
Lucas, Peter
Hommersom, Arjen
Pijnenborg, Johanna
author_role author
author2 Reijnen, Casper
Sprik, Ally
Bretová, Petra
Grube, Marcel
Vrede, Stephanie
Berg, Hege
Asberger, Jasmin
Colas, Eva
Hausnerova, Jitka
Huvila, Jutta
Gil Moreno, Antonio
Matias-Guiu, Xavier
Simons, Michiel
Snijders, Marc
Visser, Nicole
Kommoss, Stefan
Weinberger, Vit
Amant, Frederic
Bronsert, Peter
Haldorsen, Ingfrid
Koskas, Martin
Krakstad, Camilla
Küsters Vandevelde, Heidi
Mancebo, Gemma
van der Putten, Louis
de la Calle, Irene
Lucas, Peter
Hommersom, Arjen
Pijnenborg, Johanna
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Bayesian network
Endometrial cancer
Lymph node metastasis
Molecular classification
Myometrial invasion
Risk estimation
topic Bayesian network
Endometrial cancer
Lymph node metastasis
Molecular classification
Myometrial invasion
Risk estimation
description Background ENDORISK is a Bayesian network that can assist in preoperative risk estimation of lymph node metastasis (LNM) risk in endometrial cancer (EC) with consistent performance in external validations. To reflect state of the art care, ENDORISK was optimized by integrating molecular classification and preoperative assessment of myometrial invasion (MI). Methods Variables for POLE, MSI, and preoperative assessment of MI, either by expert transvaginal ultrasound or pelvic magnetic resonance imaging (MRI), were added to develop ENDORISK-2. The p53 biomarker, part of the molecular classification, was already included in ENDORISK. External validation of ENDORISK-2 for LNM prediction was performed in two independent cohorts from: Brno (CZ), (n = 581) and Tübingen (DE), (n = 247). Findings ENDORISK-2 yielded AUCs of 0·85 (95 % CI 0·80–0·90) (CZ) and 0·86 (95 % CI 0·77–0·96) (DE) for predicting LNM. In patients with low-grade histology, 83 % (CZ) and 89 % (DE) were estimated having less than 10 % risk of LNM, with false negative rates (FNR) of 4·3 % (CZ) and 2·2 % (DE). The previously defined set of minimally required variables, i.e.: preoperative tumor grade, three of the four immunohistochemical (IHC) markers, and one clinical marker, could be interchanged with the new variables, with comparable validation metrics, including AUC values of 0·79–0·87 for LNM prediction. Interpretation. Incorporation of molecular data and preoperative MI improved the flexibility of ENDORISK with comparable diagnostic accuracy for estimating LNM as when based on low-cost immunohistochemical biomarkers. In addition, the high diagnostic accuracy in patients with low-grade EC demonstrates how ENDORISK-2 could aid clinicians in identifying patients in whom surgical lymph node assessment may safely be omitted. These results underline its power for clinical use in both high and low resource countries.
publishDate 2025
dc.date.none.fl_str_mv 2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.1016/j.ejca.2025.116058
https://hdl.handle.net/10459.1/469209
http://hdl.handle.net/10459.1/469209
url https://doi.org/10.1016/j.ejca.2025.116058
https://hdl.handle.net/10459.1/469209
http://hdl.handle.net/10459.1/469209
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a https://doi.org/10.1016/j.ejca.2025.116058
European Journal of Cancer, 2025, vol. 231, 116058
dc.rights.none.fl_str_mv cc-by, (c) Marike Lombaers et al., 2025
Attribution 4.0 International
info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
rights_invalid_str_mv cc-by, (c) Marike Lombaers et al., 2025
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404961539883008
score 15,812429